Seattle startup with fresh approach to Parkinson’s and Alzheimer’s disease raises $96M Cajal Neuroscience, a Seattle startup taking a unique approach to developing treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s, revealed… Read More
